Community/Retail

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions.

Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.

New Mexico State Senator Michael Padilla plans to sponsor legislation that would require retail pharmacies to start collection programs for unused medications.

FDA has unveiled a new database that houses most FDA guidance documents for regulatory professionals.

The FDA today approved Novartis' secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Avella just announced the release of patient satisfaction data, which documents the overwhelmingly positive experience that customers have had with the national specialty pharmacy.

Community pharmacists can identify and educate patients at high risk for acute kidney injury related to use of nonsteroidal anti-inflammatory drugs.

Hospira has received 510(k) regulatory clearance from the FDA for its Plum 360 medication infusion system with Hospira MedNet safety software.

A pharmacist in Hoboken, New Jersey, was arrested for allegedly stealing morphine, fentanyl, and hydromorphone from his employer, Hoboken University Medical Center.

With Americans' use of opioids increasing, a panel from the National Institutes of Health set out to measure the drugs' effectiveness in treating long-term chronic pain, and its report suggested that the risks outweigh the benefits.

Pharmacists' antibiotic dispensing practices are improved through multifaceted educational interventions.

The Walgreens Flu Indexâ„¢ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that's as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.

The Pharmacy Quality Alliance and The American Journal of Pharmacy Benefits (AJPB) are pleased to announce a partnership in which PQA will contribute a new column to each AJPB issue entitled, Medication Quality Matters.

Gedeon Richter and Actavis today announced positive results from a phase 3 trial evaluating the efficacy and safety of cariprazine, an investigational atypical antipsychotic, in preventing relapse among schizophrenia patients.

It is not inconceivable that a physician who denies requests for opiates may not receive favorable ratings, which may impact their hospital privileges.

Beneficiary Advisory Panel Decision Sets Stage for Continued Coverage; Final Decision Rests with TRICARE Management Activity Director

A new FDA-approved drug will provide a new treatment option for adult and pediatric patients undergoing continuous renal replacement therapy.

Thoughts influence the mood swings of patients with bipolar disorder.

If you've ever been asked to fill a "genetic subscription" or had a patient confuse hydrocortisone with hydrocodone, then you know that pharmacy-related mispronunciations can be a recipe for hilarity.

Most caregivers cannot make informed decisions about OTC painkillers based on information provided in the products' labels and inserts.

A Walgreens pharmacist in Rutland, Vermont, was convicted on 2 misdemeanor charges of unlawful possession of narcotics.

A University of Florida study revealed that immunizing school children against influenza produces a ripple effect of fewer flu cases among the larger community.

Fairleigh Dickinson University professor of pharmacy practice and assistant dean for faculty Anastasia Rivkin talks about how career trends could affect the future of pharmacy.

Even a hospital pharmacist can be misinformed when it comes to vaccinations and the decision to vaccinate their own child.

Janssen announced today that the FDA has granted Priority Review designation to its New Drug Application (NDA) for paliperidone palmitate, a 3-month atypical antipsychotic for treating schizophrenia in adults.

Medication adherence monitoring is as simple as swallowing a pill.

As we are all aware, the flu vaccine is not a perfect match this season.

Because upper respiratory tract infections cost $40 billion annually in the United States, even a small reduction in incidence would have significant economic consequences.